The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Cureus | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
PDF) The renal range of the κ/λ sFLC ratio: Best strategy to evaluate multiple myeloma in patients with chronic kidney disease
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Evolution of kappa, lambda light chain level and kappa/lambda ratio (A)... | Download Scientific Diagram